Increasingly, economic data are being considered in formulary decisions. In oncology, pharmacoeconomic evaluations are essential to help decision makers weigh the associated costs and outcomes of competing
James Suver, MBA, PhD
Advertisement
Articles by James Suver, MBA, PhD
Advertisement
Latest Updated Articles
- Economic and Quality of Life Outcomes: The Four-Step Pharmacoeconomic Research Model
Published: November 1st 1995 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Zurletrectinib Generates Responses in Advanced NTRK Fusion Solid Tumors
2
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
3
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
4
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
5
